You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 20, 2025

Drug Price Trends for RAMIPRIL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for RAMIPRIL

Average Pharmacy Cost for RAMIPRIL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
RAMIPRIL 1.25 MG CAPSULE 68382-0144-06 0.08065 EACH 2025-06-18
RAMIPRIL 1.25 MG CAPSULE 62135-0271-30 0.08065 EACH 2025-06-18
RAMIPRIL 1.25 MG CAPSULE 68001-0428-00 0.08065 EACH 2025-06-18
RAMIPRIL 1.25 MG CAPSULE 57237-0222-01 0.08065 EACH 2025-06-18
RAMIPRIL 1.25 MG CAPSULE 65862-0474-01 0.08065 EACH 2025-06-18
RAMIPRIL 1.25 MG CAPSULE 57237-0222-30 0.08065 EACH 2025-06-18
RAMIPRIL 1.25 MG CAPSULE 62135-0271-01 0.08065 EACH 2025-06-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for RAMIPRIL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RAMIPRIL 10MG CAP Exelan Pharmaceuticals, Inc. 76282-0673-01 100 122.79 1.22790 EACH 2020-09-15 - 2025-09-14 FSS
RAMIPRIL 1.25MG CAP Exelan Pharmaceuticals, Inc. 76282-0670-01 100 89.42 0.89420 EACH 2020-09-15 - 2025-09-14 FSS
RAMIPRIL 2.5MG CAP Exelan Pharmaceuticals, Inc. 76282-0671-01 100 100.26 1.00260 EACH 2020-09-15 - 2025-09-14 FSS
RAMIPRIL 5MG CAP Exelan Pharmaceuticals, Inc. 76282-0672-01 100 106.99 1.06990 EACH 2020-09-15 - 2025-09-14 FSS
RAMIPRIL 5MG CAP Chartwell RX LLC 62135-0273-05 500 457.38 0.91476 EACH 2020-12-01 - 2025-08-31 FSS
RAMIPRIL 10MG CAP Chartwell RX LLC 62135-0274-01 100 110.51 1.10510 EACH 2020-12-01 - 2025-08-31 FSS
RAMIPRIL 1.25MG CAP Chartwell RX LLC 62135-0271-01 100 80.48 0.80480 EACH 2020-12-01 - 2025-08-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Ramipril Market Analysis and Price Projections

Introduction to Ramipril

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, commonly used to treat high blood pressure, heart failure, and diabetic kidney disease. It works by reducing the generation of angiotensin II, which increases blood pressure, and slowing the breakdown of bradykinin, which promotes inflammation[2,.

Market Size and Growth Projections

The global ramipril market has been experiencing steady growth driven by several key factors. As of 2021, the market size was valued at USD 550 million and is projected to reach USD 729.86 million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period from 2022 to 2029[1,.

Drivers of Market Growth

Rise in Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases such as high blood pressure and hypertension is a significant driver of the ramipril market. These conditions are becoming more common globally, leading to a higher demand for effective treatments like ramipril[2][4].

Advancements in Treatment

Improvements in the formulation of ramipril and the growing adoption of ACE inhibitors for chronic disorders are also boosting market growth. These advancements enhance the efficacy and safety of the drug, making it a preferred choice for patients and healthcare providers[1][2].

Growing Demand for Affordable Drugs

The increasing healthcare expenditure and the rising need for better and more affordable drugs are further driving the growth of the ramipril market. As healthcare costs rise, there is a greater demand for cost-effective treatments, which ramipril can provide[1][4].

Market Segmentation

By Product Type

Ramipril is available in various forms, including tablets, capsules, and solutions for oral administration. Each form has its own market share and is used based on patient needs and preferences[1].

By Indication

The primary indications for ramipril include high blood pressure, heart failure, diabetic kidney disease, and other cardiovascular conditions. The market is segmented based on these indications, with each segment contributing to the overall market growth[1][4].

By End Users

The end users of ramipril include hospitals, homecare settings, specialty clinics, and others. The demand from these sectors varies based on the healthcare infrastructure and patient needs in different regions[1].

By Distribution Channel

Ramipril is distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies. The distribution channel plays a crucial role in making the drug accessible to a wider audience[1].

Regional Landscape

North America

North America dominates the ramipril market due to several government initiatives and increasing funding for improving cardiovascular disease treatments. The region is expected to continue its growth trajectory during the forecast period[1][2].

Asia-Pacific

The Asia-Pacific region is projected to experience significant growth in the ramipril market. This growth is driven by advancements in healthcare amenities and increased government initiatives in the region[1][2].

Impact of COVID-19

The COVID-19 pandemic has had a significant impact on the pharmaceutical industry, including the ramipril market. The pandemic led to an increased demand for routinely used medications, including those for COVID-19 management. This surge in demand presented opportunities for manufacturers, although it also posed challenges such as supply chain disruptions and stock shortages[1][4].

Competitive Landscape

The ramipril market is competitive, with several key players including Pharmanova Limited, Wockhardt, Perrigo Company plc, Aurobindo Pharma, Amneal Pharmaceuticals LLC, Dr. Reddy’s Laboratories Ltd, and others. These companies are involved in continuous research and development to improve the formulation and efficacy of ramipril[4].

Price Projections

The prices of ramipril vary based on the dosage and quantity. Here are some approximate price ranges for different dosages:

  • 1.25 mg Oral Capsule: From $24.19 for 30 capsules to $41.63 - $58.46 for 100 capsules[5].
  • 2.5 mg Oral Capsule: From $27.62 for 90 capsules to $33.95 - $60.27 for 100 capsules[5].
  • 5 mg Oral Capsule: From $35.60 for 100 capsules to $64.07 for 90 capsules[5].
  • 10 mg Oral Capsule: From $39.48 for 100 capsules to $61.57 for 90 capsules[5].

These prices are subject to variation based on the pharmacy, location, and availability.

Opportunities and Challenges

Opportunities

  • Increased research and development on ramipril, along with emerging market regulations and financial donations from governing bodies, are expected to create new opportunities for the market[1][2][4].
  • Expanding healthcare access and rising awareness about cardiovascular diseases are also expected to drive market growth.

Challenges

  • Side effects of the drug, such as rectum bleeding and stomach cramping, can hinder market growth[4].
  • Generic competition and pricing pressures are other challenges that the market faces.

Key Takeaways

  • The global ramipril market is projected to grow significantly due to the increasing prevalence of cardiovascular diseases and advancements in treatment.
  • North America and Asia-Pacific are key regions driving the market growth.
  • The market is competitive with several major players involved in continuous R&D.
  • Price variations exist based on dosage and quantity, with a general trend of affordability.

FAQs

Q: What is the primary use of ramipril? A: Ramipril is primarily used to treat high blood pressure, heart failure, and diabetic kidney disease.

Q: What is the projected market size of ramipril by 2029? A: The market is expected to reach USD 729.86 million by 2029, growing at a CAGR of 3.6% from 2022 to 2029[1].

Q: Which regions are expected to drive the growth of the ramipril market? A: North America and the Asia-Pacific region are expected to drive the growth of the ramipril market due to government initiatives and advancements in healthcare[1][2].

Q: How has COVID-19 impacted the ramipril market? A: COVID-19 has led to increased demand for medications, including those for COVID-19 management, presenting both opportunities and challenges for ramipril manufacturers[1][4].

Q: What are the common side effects of ramipril? A: Common side effects of ramipril include rectum bleeding and stomach cramping[4].

Sources

  1. Data Bridge Market Research - Global Ramipril Market Size, Scope & Growth Opportunities By 2029.
  2. BioSpace - Ramipril Market Market Outlook, Competitive Landscape ... - BioSpace.
  3. The Business Research Company - Global ACE Inhibitors Market Report 2024.
  4. Allied Market Research - Ramipril Market Insight Data, Size, Industry Growth, 2030.
  5. Drugs.com - Ramipril Prices, Coupons, Copay Cards & Patient Assistance.
Last updated: 2025-01-01

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.